Multiple sclerosis: open trials in Sweden

15 open trials have a site in Sweden. Registry data; only the trial team decides who can take part.

NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg
Registry updated 2026-11-03
NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Karolinska Universitetssjukhuset, Huddinge, Stockholm · Region Stockholm – SLSO, Stockholm
Registry updated 2026-10-27
NCT07517185
The HIt HArd and hiT Early in Multiple Sclerosis Trial
Trial Treatment · Phase 2 · Uppsala University
Region Dalarna, Falun · Region Gaevleborg, Gavle · Region Vaermland, Karlstad · Uppsala University Hospital, Uppsala
Registry updated 2026-10-22
2024-512914-16-00
A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
Trial Treatment · Phase 3 · Amgen Inc.
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg
Registry updated 2026-10-20
NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Novartis Investigative Site, Gothenburg · Novartis Investigative Site, Stockholm
Registry updated 2026-10-13
NCT05901259
The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes
Research · Otto Bock Healthcare Products GmbH
Ottobock Care Sverige, Bergshamra
Registry updated 2026-09-14
2025-521546-23-00
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Karolinska University Hospital, Huddinge
Registry updated 2026-07-30
2025-523892-50-00
A Randomized Open Label Trial Exploring the Soluble and Imaging Biomarker Dynamic Responses to Tolebrutinib Compared to Rituximab Treatment in Patients with Multiple Sclerosis (MS)
Trial Treatment · Phase 3 · Region Stockholm – SLSO
Region Stockholm – SLSO, Stockholm
Registry updated 2026-06-02
NCT05819008
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
Research · Umeå University
Umeå University Hospital, Umeå
Registry updated 2026-04-01
NCT07380295
Improving Workforce Participation and Well-Being in Individuals With Multiple Sclerosis - A Feasability Study
Research · Region Gävleborg
Gävle Hospital, Gävle
Registry updated 2026-02-02
NCT07149662
Immune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During Pregnancy
Research · Region Stockholm
Academic specialist center, Center for Neurology, Stockholm
Registry updated 2025-11-25
NCT07211516
Relationship Between Cognition, Workforce Participation and Well-Being in Individuals With Multiple Sclerosis
Research · Region Gävleborg
Gävle Hospital, Gävle
Registry updated 2025-10-08
NCT07131553
Evaluation of the Wheelchair School (Drivkraft) a Clinical Study
Trial Treatment · Karolinska Institutet
Aleris Rehab Station, Solna
Registry updated 2025-08-20
NCT06312046
Motor-cognitive Performance in People With Multiple Sclerosis
Trial Treatment · Karolinska Institutet
Karolinska Institutet, Stockholm
Registry updated 2025-07-10
NCT06973018
Internet Delivered Cognitive Rehabilitation for Mild Cognitive Impairments
Trial Treatment · Aniko Bartfai
Danderyd Hospital, Stockholm
Registry updated 2025-05-15

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error